A phase II trial of all- trans -retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis

1997 ◽  
Vol 39 (4) ◽  
pp. 349-356 ◽  
Author(s):  
D. L. Trump ◽  
David C. Smith ◽  
Dwight Stiff ◽  
Adedayo Adedoyin ◽  
Roger Day ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
Retinoic Acid ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Pharmacokinetic Analysis ◽  
Hormone Refractory Prostate Cancer ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid ◽  
Hormone Refractory

Phase II trial of weekly docetaxel, zoledronic acid and selenium for hormone refractory prostate cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16113-16113
Author(s):  
J. G. Kattan ◽  
M. Ghosn ◽  
G. Chahine ◽  
A. Saroufim ◽  
F. Nasr ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Zoledronic Acid ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Weekly Docetaxel ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document